January 21st, 2021
10:00AM EST - 11:00AM EST
ERA21 Webinar Series
In this webinar, Emilie Da Silva will present "The lung surfactant bioassay: principles, procedures, and potential regulatory use”.
The presentation will explore the adequacy and the regulatory readiness of the lung surfactant bioassay for the hazard identification of airborne compounds. The putative outcome pathway AOP 302 leading to immediate adverse lung effects will be outlined. Then, the lung surfactant bioassay will be described and the suitability of the method to predict adverse lung effects in humans and rodents will be presented. Finally, the regulatory readiness of the method will be addressed.